Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Addex Therapeutics Ltd (ADXN) Stock · SELL · CRISIS | LOPJLB

Addex Therapeutics Ltd (ADXN)

Healthcare · Biotechnology · NASDAQ · CH

$3.18+2.58%Close

SELLCRISIS · day 7

ADXN▼ SELL

$3.18+2.58%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $2M
Beta: 1.96
P/E (TTM): -0.48

Short % float: 0.05%
Days to cover: 1.0
SI change: -93.5%

1W: +7.80%
1M: -12.88%

vs SPY 1W: +5.85%
vs SPY 1M: -14.28%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves…

Employees: 3
Headquarters: CH
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 720.3K
Float: 80.3%

addextherapeutics.com ↗

Key executives

Timothy Mark Dyer — Co-Founder, Chief Executive Officer & Director

Roger G. Mills — Chief Medical Officer & Director

Mikhail Kalinichev — Head of Translational Science

SEC filings

EDGAR · CIK 15742320 · ADXN

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish1100.0%

Neutral00.0%

Bearish00.0%

L $30.00Avg $30.00H $30.00

Target$30.00+843.40%

Last$3.18

Company news

globenewswire.com · 6d ago

Addex Therapeutics Announces Executive Management Changes

defenseworld.net · 9d ago

What Addex Therapeutics (ADXN) Said on Its Q2 Earnings Call

seekingalpha.com · 9d ago

Addex Therapeutics Ltd (ADXN) Q2 2026 Earnings Call Transcript

globenewswire.com · 10d ago

Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update

globenewswire.com · 13d ago

Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior

globenewswire.com · 14d ago

Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026

globenewswire.com · 43d ago

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027

Market news & ticker search · RSS for ADXN

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE